- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00576160
Improving Medication Adherence in Post-ACS Patients
Improving Med Adherence in Post-ACS Patients: Phase 1B Dose-Finding RCT
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- La phase 1
Contacts et emplacements
Lieux d'étude
-
-
New York
-
New York, New York, États-Unis, 10032
- Columbia University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Medical eligibility:
- Patient presenting for staged intervention with positive cardiac history OR
- Patient with stable CAD who received cardiac admission but does not report chest pain. OR
- Patient with stable CAD who has had a cardiac admission in the past.
- Patient is non-adherent to prescribed medication.
The following exclusion criteria have been set for either safety concerns or concerns that patients will not be able to complete the protocol:
- inability to communicate in English or Spanish
- unwilling to be randomized or to have aspirin in a separate bottle if they use a pill box
- unavailability for the 1 month period of the study (including being unavailable by phone and/or traveling out of the country)
- medically unable to receive aspirin (e.g. allergy, contra-indicated, etc)
- deemed unable to comply with the protocol (either self selected or by indicating during screening that s/he could not complete all requested tasks). This includes patients with a level of cognitive impairment indicative of dementia, and patients with current alcohol or substance abuse.
- deemed to need immediate psychiatric assessment (e.g., must be hospitalized, or have some other psychiatric intervention conducted within 72 hours).
- active psychosis, bipolar disorder, or any overt personality disorder
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: A
Participants will complete Baseline and 30-day assessment visit. At both visits BDI II, Self-Efficacy Questions, AEs Assessment, and Treatment Satisfaction will be assessed. A MEMS cap will be used during the 30-day period to asses medication adherence to their prescribed aspirin. Usual Care: Participants assigned to UCC will only receive the pre- and post-assessment session, and any adherence education or encouragement that is regularly provided by their treating physicians. |
|
Expérimental: B
Participants will complete Baseline and 30-day assessment visit.
At both visits BDI II, Self-Efficacy Questions, AEs Assessment, and Treatment Satisfaction will be assessed.
A MEMS cap will be used during the 30-day period to asses medication adherence to their prescribed aspirin.
After Baseline, there is an initial session telephone session with PST therapist.
Subsequent treatment sessions provide a context for the patient to discuss the problems and difficulties they face and that give rise to medication non-adherence.
|
Problem-Solving Therapy (PST) is a behavioral approach that teaches patients how to systematically solve their own behavioral difficulties.
During telephone treatment sessions, the patient will discuss the problems and difficulties they face and that give rise to medication non-adherence.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Prevalence of medication adherence
Délai: 30 days
|
30 days
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Karina W. Davidson, PhD, Columbia University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AAAB9215
- K24HL084034 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur PST therapy
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH); Washington University School of... et autres collaborateursRecrutementLa dépression | AnxiétéÉtats-Unis
-
University of Texas at AustinBaylor College of Medicine; University of Kansas Medical CenterComplété
-
University of Sao Paulo General HospitalComplétéChondromalacie rotulienneBrésil
-
University of OttawaOttawa Hospital Research InstituteRetiréSuicide | Automutilation intentionnelleCanada
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)RecrutementAccident vasculaire cérébral | Aphasie | Aphasie Non FluentÉtats-Unis
-
Lawson Health Research InstituteBell Let's Talk Community FundComplété
-
Columbia UniversityRésilié
-
University of Lausanne HospitalsRésilié
-
NeuroTronik Inc.InconnueInsuffisance cardiaque | Insuffisance cardiaque aiguëParaguay
-
University of Texas Southwestern Medical CenterHackensack Meridian Health; Kessler Institute for Rehabilitation; Baylor Health...ComplétéPartenaires de soins des patients atteints de lésions cérébrales traumatiques (TBI)États-Unis